Article Details

Ocular Therapeutix (NASDAQ:OCUL) Rating Lowered to Sell at Zacks Investment Research

Retrieved on: 2019-07-15 18:52:30

Tags for this article:

Click the tags to see associated articles and topics

Ocular Therapeutix (NASDAQ:OCUL) Rating Lowered to Sell at Zacks Investment Research. View article details on hiswai:

Excerpt

<div>Finally, <b>Two Sigma Investments</b> LP raised its holdings in shares of Ocular Therapeutix by 269.5% in the 4th quarter. <b>Two Sigma Investments</b> LP now ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo